Literature DB >> 7526273

Changed excretion of urinary proteins and enzymes by chronic exposure to lead.

M Pergande1, K Jung, S Precht, L M Fels, C Herbort, H Stolte.   

Abstract

Fifteen various serum and urine parameters were evaluated as indicators of renal alterations induced by lead in 82 male workers of a battery plant chronically exposed to lead (median of blood lead concentration: 2.03 mumol/l). The control group comprised 44 non-exposed healthy volunteers (0.34 mumol/l). High-molecular-mass proteins (transferrin, immunoglobulin G (IgG), (albumin)) were determined in urine as markers of glomerular integrity; low-molecular-weight proteins and parenchymal enzymes (alpha 1-microglobulin, beta 2-microglobulin, retinol-binding protein, lysozyme, ribonuclease, N-acetyl-beta-D-glucosaminidase (NAG), alanine aminopeptidase (AAP), alkaline phosphatase (AP), gamma-glutamyltransferase (GGT)) as indicators of changes in the proximal tubule; Tamm-Horsfall glycoprotein and kallikrein as markers of the distal tubule. There was a positive correlation between tubular indicators and blood lead concentration as well as the erythrocyte protoporphyrin (EPP). About 30% of the lead-exposed workers showed an increased excretion of alpha 1-microglobulin, NAG, ribonuclease, and/or Tamm-Horsfall protein, whereas the glomerular indicators remained unchanged. The combined determination of NAG and alpha 1-microglobulin in urine could be helpful in the early detection of lead-induced changes in the nephron.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526273     DOI: 10.1093/ndt/9.6.613

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Urinary enzymatic markers (N-acetyl-beta-D-glucosaminidase) in assessing the tubulointerstitial compartment in chronic glomerulonephritis related to odontogenic foci.

Authors:  Silvia Velciov; Gheorghe Gluhovschi; Romulus Timar; Cristina Gluhovschi; Ligia Petrica; Flaviu Bob; Gheorghe Bozdog; Marius Pricop; Adrian Gluhovschi; Marioara Cornianu; Elena Potencz; Bogdan Timar; Adriana Kaycsa
Journal:  Wien Klin Wochenschr       Date:  2015-09-16       Impact factor: 1.704

2.  Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: a cross-sectional study.

Authors:  Shanika Nanayakkara; S T M L D Senevirathna; Upul Karunaratne; Rohana Chandrajith; Kouji H Harada; Toshiaki Hitomi; Takao Watanabe; Tilak Abeysekera; T N C Aturaliya; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2011-06-28       Impact factor: 3.674

3.  Megalin knockout mice as an animal model of low molecular weight proteinuria.

Authors:  J R Leheste; B Rolinski; H Vorum; J Hilpert; A Nykjaer; C Jacobsen; P Aucouturier; J O Moskaug; A Otto; E I Christensen; T E Willnow
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  Associations of lead biomarkers with renal function in Korean lead workers.

Authors:  V M Weaver; B-K Lee; K-D Ahn; G-S Lee; A C Todd; W F Stewart; J Wen; D J Simon; P J Parsons; B S Schwartz
Journal:  Occup Environ Med       Date:  2003-08       Impact factor: 4.402

Review 5.  Renal effects of environmental and occupational lead exposure.

Authors:  M Loghman-Adham
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

6.  Blood Lead Level and Renal Impairment among Adults: A Meta-Analysis.

Authors:  Saruda Kuraeiad; Manas Kotepui
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

Review 7.  Nephrotoxic Biomarkers with Specific Indications for Metallic Pollutants: Implications for Environmental Health.

Authors:  István Pócsi; Mark E Dockrell; Robert G Price
Journal:  Biomark Insights       Date:  2022-07-14

8.  The Effects of Lead Exposure on Serum Uric Acid and Hyperuricemia in Young Adult Workers: A Cross-sectional Controlled Study.

Authors:  Ali Erdem Baki; Timur Ekiz; Gökhan Tuna Öztürk; Engin Tutkun; Hınç Yilmaz; Mustafa Turgut Yildizgören
Journal:  Arch Rheumatol       Date:  2016-03-22       Impact factor: 1.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.